| Experiment name | Clinical attributes |
| Cuadras02_Infection_6_RRVb_1h_vs_mocka_1h |
| Detweiler01_E3_U937_mock_1ha | Macrophages (Stimulated immune*), Monocytes (Stimulated immune*), Hematologic samples and cell lines (Stimulated immune*), Hematologic cancer and cell line (Stimulated immune*) |
| Perou00_BC115A_AF | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*) |
| Ross00_HT_29_CL4001_COLON | Colon cancer cell line (NCI60), Fast doubling (20-40) cell lines (NCI60), Colon tissue, cancer or cell line (NCI60), Colon cancer or cell line (NCI60), Cell line (NCI60*), Cancer and cell line (NCI60*) |
| Whitfield02_34h_Thy_Noc_Exp4 | Cell line (HeLa cell cycle*), Epithelial cell line (HeLa cell cycle*), HeLa cell line (HeLa cell cycle*), Cancer and cell line (HeLa cell cycle*), M phase (HeLa cell cycle) |